secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001493152-23-020163
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology Holdings effects 1-for-10 reverse stock split
-----------------------------------------------------------------

- Reverse stock split effective June 2, 2023; every 10 shares combined into 1.
- Stockholders approved the split at a Special Meeting on May 26, 2023.
- Common stock begins trading on Nasdaq on a split-adjusted basis June 5, 2023.
- No fractional shares issued; any fractional share rounded up to nearest whole share.
- Proportionate adjustments made to options, warrants, and Series A Preferred conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/0001493152-23-020163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315223020163/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-020163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer